THULL R.Surface functionalization of materials to initiateauto-biocompatibilization in vivo[J].MaterialwissWerkst,2001,32(12):949-952.
[2]
VENKATRAMAN P.Micelle-like nanoparticles of star-branched PEO-PLA copolymers as chemotherapeutic carrier[J].J Controlled Release,2005,110:20-33.
[3]
XU R L,WINNIK M A,HALLET F R,et al.Light-scattering study of the association behavior of styreneethylene-oxide block copolymers in aqueous-solution[J].Macromolecules,1991,24:87-93.
[4]
FORREST M L,WON C Y,MALICK A W,et al.In vitrorelease of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(ε-caprolactone)micelles[J].JControlled Release,2006,110:370-377.
[5]
尹常晴,隋卫平,汪源浩.两亲性高分子聚集体在药物载体中的应用[J].化学通报,2006,69(4):1-7.YIN Chang-qing,SUI Wei-ping,WANG Yuan-hao.Theapplication of amphiphilic polymer aggregates as drugcarrier[J].Chemsitry,2006,69(4):1-7.(in Chinese)
[6]
YANG L,ALEXANDRIDIS P.Physicochemical aspects ofdrug delivery and release from polymer-based colloids[J].Curr Opin Colloid Interface Sci,2000,5(1/2):132-143.
[7]
GOPERFERICH A,PETER S J,LUCHE A.Modulationof marrow stromal cell function using poly(D,L-lacticacid)-block-poly(ethylene glycol)-monomethyl ethersurfaces[J].J Biomed Mater Res,1999,47:390-398.
[8]
SUN H,HWANG Y S,LEE J E,et al.Behavior ofosteoblasts on a type I atelocollagen grafted ozone oxidizedpoly L-lactic acid membrane[J].Biomaterials,2001,22:219-230.
[9]
HARRISON J H.Dextran as a plasma substitute withplasma volume and excretion studies on control patients[J].Ann Surg,1954,139:137-142.
[10]
BAJGAI M P,ARYAL S,LEE D R,et al.Physicochemical characterization of self-assembled poly(epsilon-caprolactone)grafted dextran nanoparticles[J].Colloid Polym Sci,2008,286:517-524.
[11]
NOUVEL C C,DUBOIS P,DELLACJERIE E.Controlled synthesis of amphiphilic biodegradablepolylactide-grafted dextran copolymers[J].Journal ofPolymer Science:Part A Polymer Chemistry,2004,42:2577-2588.
[12]
JIANG L,ZHANG J W,WOLCOTT M P.Comparison ofpolylactide/nano-sized calcium carbonate and polylactide/montmorillonite composites:reinforcing effects andtoughening mechanisms[J].Polymer,2007,48:7632-7644.
[13]
AURAS R,HARTE B,SELKE S.An overview ofpolylactides as packaging materials[J].MacromolBiosei,2004,4(9):835-864.
[14]
JEONG B,BAE Y H,LEE D S,et al.Biodegradableblock copolymers as injectable drug delivery system[J].Nature,1997,388:860-862.
[15]
CAI Q,WAN Y Q,BEI J Z.Synthesis andcharacterization of biodegradable polylactide-grafteddextran and its application as compatilizer[J].Biomaterials,2003,24:3555-3562.
[16]
HAN S Y,WU Y.Nanoparticle carriers based oncopolymers of poly(L-aspartic acid co-L-lactide)-1,2-dipalmitoyl-sn-glycerol-3-phosphoethanolamine for drugdelivery[J].J Nanopart Res,2011,13:4371-4385.
